
INMB Valuation
INmune Bio Inc
- Overview
- Forecast
- Valuation
- Earnings
INMB Relative Valuation
INMB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, INMB is overvalued; if below, it's undervalued.
Historical Valuation
INmune Bio Inc (INMB) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -5.30. The fair price of INmune Bio Inc (INMB) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:2.35
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.84
P/B
Median3y
3.68
Median5y
3.74
-50.84
FCF Yield
Median3y
-15.32
Median5y
-13.13
Competitors Valuation Multiple
The average P/S ratio for INMB's competitors is 2.15, providing a benchmark for relative valuation. INmune Bio Inc Corp (INMB) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of 257.14%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

WHG
Westwood Holdings Group Inc
17.860
USD
+5.31%

VTYX
Ventyx Biosciences Inc
3.020
USD
+2.37%

MPAA
Motorcar Parts of America Inc
11.760
USD
+5.00%

TSQ
Townsquare Media Inc
7.280
USD
+1.68%

ALTO
Alto Ingredients Inc
1.240
USD
+0.81%

SGMT
Sagimet Biosciences Inc
9.600
USD
+8.72%

OPRT
Oportun Financial Corp
6.400
USD
+3.23%

HOFT
Hooker Furnishings Corp
10.890
USD
+1.49%

VERU
Veru Inc
0.570
USD
-1.72%

TDTH
Trident Digital Tech Holdings Ltd
2.240
USD
+12.00%
FAQ

Is INmune Bio Inc (INMB) currently overvalued or undervalued?
INmune Bio Inc (INMB) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -5.30. The fair price of INmune Bio Inc (INMB) is between to according to relative valuation methord.

What is INmune Bio Inc (INMB) fair value?

How does INMB's valuation metrics compare to the industry average?

What is the current P/B ratio for INmune Bio Inc (INMB) as of Jul 23 2025?

What is the current FCF Yield for INmune Bio Inc (INMB) as of Jul 23 2025?

What is the current Forward P/E ratio for INmune Bio Inc (INMB) as of Jul 23 2025?
